Compass Therapeutics (CMPX) Earnings Date & Reports

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CMPX is expected to report earnings to fall 11.73% to -9 cents per share on May 12

Compass Therapeutics CMPX Stock Earnings Reports

Q1'25

Est.

$-0.10

Q4'24

Missed

by $0.01

Q3'24

Beat

by $0.03

Q2'24

Est.

$-0.10

Q1'24

Beat

by $0.03

The last earnings report on February 28 showed earnings per share of -10 cents, missing the estimate of -10 cents. With 1.06M shares outstanding, the current market capitalization sits at 399.01M.

View a ticker or compare two or three

Compare

CMPX